Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,042.62, with a market capitalization of 988.47B. The stock trades at a price-to-earnings (P/E) ratio of 52.32 and offers a dividend yield of 56.7%.
As of 2025-12-02, Eli Lilly(LLY) stock has fluctuated between $1,040.36 and $1,068.18. The current price stands at $1,042.62, placing the stock +0.2% above today's low and -2.4% off the high.
Eli Lilly(LLY) shares are trading with a volume of 3.28M, against a daily average of 3.77M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Analysts at Bernstein just reiterated an outperform rating on Apple, noting that its checks show iPhone sales are strong . Analysts at Bank of America reiterat...
Eli Lilly shares have added over a third of their value in 2025, thanks in part to strong sales of the company's weight-loss drugs. Close...
Eli Lilly and Co. (NYSE:LLY) on Monday announced that Zepbound (tirzepatide) single-dose vials will now be available at lower prices on LillyDirect, the company...
Analyst ratings
74%
of 31 ratingsMore LLY News
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, Li...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Quantitative Momentum In...
Things are changing rapidly in the pharmaceutical sector, but Eli Lilly remains in the pole position in weight loss drugs. Shares of Eli Lilly (LLY 2.61%) have...
Key Points Both of these stocks are growing by leaps and bounds. MercadoLibre boasts a cohesive ecosystem that is driving revenue and profits forward. Eli Li...
Ever wondered if Eli Lilly’s massive popularity actually means it is a good value right now? You are not alone. Figuring out if a stock justifies its price is h...
Close Key Takeaways The possibility of adding a new Big Tech customer helped lift an American chipmaker's stock on Friday, Nov. 28, 2025, while a recently hot...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...